News: Tate & Lyle PLC (BD15_p.L)

BD15_p.L on London Stock Exchange

--GBp
8 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
--
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
215
52-wk High
105.00p
52-wk Low
93.00p

Search Stocks
Select another date:

Thu, Nov 13 2014

Law firm mergers create conflicts for companies

NEW YORK - After Patton Boggs merged with Squire Sanders, the new law firm, Squire Patton Boggs, dropped Patton Boggs' client, Tate & Lyle, because it represents a group of U.S. sugar companies that are suing Tate and others for falsely billing its high-fructose corn syrup as "just like sugar."

Law firm mergers create conflicts for companies

NEW YORK, Nov 13 - After Patton Boggs merged with Squire Sanders, the new law firm, Squire Patton Boggs, dropped Patton Boggs' client, Tate & Lyle, because it represents a group of U.S. sugar companies that are suing Tate and others for falsely billing its high-fructose corn syrup as "just like sugar."

UPDATE 1-Tate & Lyle posts lower profit, sticks to outlook

LONDON, Nov 6 - Tate & Lyle reported sharply lower profit and sales for the first half of its fiscal year on Thursday, but the results were better than expected after a surprise profit warning in September that sent its shares reeling.

Tate & Lyle posts lower first-half profit, sticks to outlook

LONDON, Nov 6 - Tate & Lyle reported sharply lower profit and sales for the first half of its fiscal year on Thursday, hurt by supply chain disruptions and increased competition in the market for its Splenda sweetener.

Ebola, economic scares weigh on Britain's FTSE

LONDON, Oct 8 - Britain's main equity index fell for a second day on Wednesday as worries about Ebola reaching Europe hurt travel firms and telecoms tester Spirent Communication became the latest UK company to warn on profits.

UK FTSE 100 set for steepest weekly drop in 15 months

LONDON, Sept 26 - Britain's main equity index was on track for its biggest weekly loss in 15 months on Friday as two new profit warnings added to a gloomy mood for shares, hit by expectations of monetary tightening in Britain and the United States.

FTSE falls, led by pharma, as U.S. tax rules dim M&A prospects

LONDON, Sept 23 - Britain's top shares fell on Tuesday, dragged down by healthcare shares, as new U.S. tax rules made it less likely companies such as Shire and AstraZeneca would become takeover targets.

Pharma shares knock FTSE as new U.S. tax rules dent M&A hopes

LONDON, Sept 23 - Britain's top shares fell on Tuesday, dragged down by healthcare shares as new U.S. tax rules dented the takeover appeal of companies such as Shire and AstraZeneca.

UK profit warnings prompt investor wake-up call

* Price gap relative to Europe will keep closing-strategist

UPDATE 2-Tate & Lyle shares plunge to 3-year low after profit warning

* Sucralose prices seen down 25 pct this year, not 15 pct

Select another date:
Search Stocks